Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation

Following binding of platelet-derived growth factor (PDGF), the PDGF alpha receptor (alphaPDGFR) becomes tyrosine phosphorylated and associates with a number of signal transduction molecules, including phospholipase Cgamma-1 (PLCgamma-1), phosphatidylinositol 3-kinase (PI3K), the phosphotyrosine phosphatase SHP-2, Grb2, and Src. Here, we present data identifying a novel phosphorylation site in the kinase insert domain of the alphaPDGFR at tyrosine (Y) 720. We replaced this residue with phenylalanine and expressed the mutated receptor (F720) in Patch fibroblasts that do not express the alphaPDGFR. Characterization of the F720 mutant indicated that binding of two proteins, SHP-2 and Grb2, was severely impaired, whereas PLCgamma-1 and PI3K associated to wild-type levels. In addition, mutating Y720 to phenylalanine dramatically reduced PDGF-dependent tyrosine phosphorylation of SHP-2. Since Y720 was required for recruitment of two proteins, we investigated the mechanism by which these two proteins associated with the alphaPDGFR. SHP-2 bound the alphaPDGFR directly, whereas Grb2 associated indirectly, most probably via SHP-2, as Grb2 and SHP-2 coimmunoprecipitated when SHP-2 was tyrosine phosphorylated. We also compared the ability of the wild-type and F720 alphaPDGFRs to mediate a number of downstream events. Preventing the alphaPDGFR from recruiting SHP-2 and Grb2 did not compromise PDGF-AA-induced activation of Ras, initiation of DNA synthesis, or growth of cells in soft agar. We conclude that phosphorylation of the alphaPDGFR at Y720 is required for association of SHP-2 and Grb2 and tyrosine phosphorylation of SHP-2; however, these events are not required for the alphaPDGFR to activate Ras or initiate a proliferative response. In addition, these findings reveal that while SHP-2 binds to both of the receptors, it binds in different locations: to the carboxy terminus of the betaPDGFR but to the kinase insert of the alphaPDGFR.

[1]  A. Kazlauskas,et al.  Expression of PDGF, VEGF and their receptors in non-small cell lung tumor cell lines. , 1996, International journal of oncology.

[2]  H. Inui,et al.  Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. , 1994, The Journal of biological chemistry.

[3]  A. Ullrich,et al.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. , 1993, Science.

[4]  C. Fitzer-Attas,et al.  Mouse platelet-derived growth factor alpha receptor: sequence, tissue-specific expression and correlation with metastatic phenotype. , 1992, Oncogene.

[5]  W. Richardson,et al.  A role for platelet-derived growth factor in normal gliogenesis in the central nervous system , 1988, Cell.

[6]  M. Endo,et al.  Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Betsholtz,et al.  PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis , 1996, Cell.

[8]  M. Ruggiero,et al.  Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction , 1991, Molecular and cellular biology.

[9]  J. Cooper,et al.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src , 1986, Molecular and cellular biology.

[10]  C. Heldin,et al.  Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Tony Pawson,et al.  Protein modules and signalling networks , 1995, Nature.

[12]  B. Neel,et al.  The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early xenopus development , 1995, Cell.

[13]  T. Pawson,et al.  The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D F Bowen-Pope,et al.  A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells. , 1992, Development.

[15]  Jonathan A. Cooper,et al.  A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase , 1994, Molecular and cellular biology.

[16]  S. Shoelson,et al.  Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. , 1994, The Journal of biological chemistry.

[17]  Nanxin Li,et al.  Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis , 1992, Nature.

[18]  A. van Koppen,et al.  Regulation and role of PDGF receptor alpha-subunit expression during embryogenesis. , 1992, Development.

[19]  J. Schlessinger.  SH2/SH3 signaling proteins. , 1994, Current opinion in genetics & development.

[20]  B. Neel,et al.  Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression , 1996, Molecular and cellular biology.

[21]  J. Escobedo,et al.  Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis , 1992, Nature.

[22]  W. Richardson,et al.  Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture , 1988, Nature.

[23]  A. Kazlauskas,et al.  Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively , 1993, Molecular and cellular biology.

[24]  W. Richardson,et al.  Cell death and control of cell survival in the oligodendrocyte lineage , 1992, Cell.

[25]  B. Margolis,et al.  Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. , 1994, Oncogene.

[26]  W. Snider,et al.  Developmental expression of the platelet-derived growth factor alpha-receptor gene in mammalian central nervous system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Heldin,et al.  Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF alpha- and beta-receptor signals in cells expressing both receptor types. , 1992, The Journal of biological chemistry.

[28]  C. Heldin,et al.  Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. , 1988, Science.

[29]  E. Wilander,et al.  Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. , 1993, Cancer research.

[30]  C. Heldin,et al.  Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation , 1994, Molecular and cellular biology.

[31]  Philippe Soriano,et al.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.

[32]  A. van Koppen,et al.  PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction. , 1993, The Journal of biological chemistry.

[33]  K. Irie,et al.  Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction , 1995, Science.

[34]  S. Courtneidge.  Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation. , 1985, The EMBO journal.

[35]  C. Heldin,et al.  Expression of Platelet-Derived Growth Factor (PDGF) and PDGF α- and β-Receptors in the Peripheral Nervous System: An Analysis of Sciatic Nerve and Dorsal Root Ganglia , 1993 .

[36]  Jonathan A. Cooper,et al.  Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. , 1992, The EMBO journal.

[37]  A. Kazlauskas,et al.  Identification of a Putative Syp Substrate, the PDGFβ Receptor (*) , 1995, The Journal of Biological Chemistry.

[38]  C. Fitzer-Attas,et al.  Expression of functionally intact pdgf‐α receptors in highly metastatic 3ll lewis lung carcinoma cells , 1993 .

[39]  J. Biggers,et al.  Expression of mouse PDGF-A and PDGF α-receptor genes during pre- and post-implantation development: Evidence for a developmental shift from an autocrine to a paracrine mode of action , 1992, Mechanisms of Development.

[40]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[41]  G. Carpenter,et al.  Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. , 1994, Oncogene.

[42]  A. Saltiel,et al.  Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. , 1994, The Journal of biological chemistry.

[43]  Jonathan A. Cooper,et al.  GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit , 1992, Molecular and cellular biology.

[44]  W. Snider,et al.  PDGF A-chain gene is expressed by mammalian neurons during development and in maturity , 1991, Cell.

[45]  T Pawson,et al.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav , 1994, Molecular and cellular biology.

[46]  Jonathan A. Cooper,et al.  Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins , 1989, Cell.

[47]  S. Shamah,et al.  Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells , 1993, Molecular and cellular biology.

[48]  T. Libermann,et al.  Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.

[49]  D A Stephenson,et al.  Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Neel,et al.  Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue, SH-PTP2. , 1993, The Journal of biological chemistry.

[51]  A. Kazlauskas,et al.  Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal , 1993, Cell.

[52]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[53]  A. Kazlauskas.  Receptor tyrosine kinases and their targets. , 1994, Current opinion in genetics & development.

[54]  S. Aaronson,et al.  Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions. , 1993, The Journal of biological chemistry.

[55]  C. Heldin,et al.  Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant , 1993, Molecular and cellular biology.

[56]  T. Pawson,et al.  SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. , 1993, Science.

[57]  I. S. Kim,et al.  Human microvascular endothelial cells express receptors for platelet-derived growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Ross,et al.  The platelet-derived growth factor receptor. , 1985, The International journal of neuroscience.

[59]  Weiqun Li,et al.  Differential Requirement of a Motif within the Carboxyl-terminal Domain of α-Platelet-derived Growth Factor (αPDGF) Receptor for PDGF Focus Forming Activity Chemotaxis, or Growth (*) , 1995, The Journal of Biological Chemistry.

[60]  U. Hellman,et al.  Demonstration of Functionally Different Interactions between Phospholipase C-γ and the Two Types of Platelet-derived Growth Factor Receptors (*) , 1995, The Journal of Biological Chemistry.

[61]  M. Waterfield,et al.  Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil , 1988, Nature.

[62]  A. Kazlauskas,et al.  The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. , 1994, Oncogene.

[63]  C. Heldin,et al.  PDGF alpha‐ and beta‐receptors activate unique and common signal transduction pathways. , 1992, The EMBO journal.

[64]  C. Heldin,et al.  Neurotrophic activity of platelet-derived growth factor (PDGF): Rat neuronal cells possess functional PDGF beta-type receptors and respond to PDGF. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[65]  C. Walsh,et al.  Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[66]  L. Claesson-Welsh,et al.  Platelet-derived growth factor receptor signals. , 1994, The Journal of biological chemistry.

[67]  R. Storb,et al.  L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential. , 1991, Human gene therapy.

[68]  C. Turck,et al.  Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways , 1992, Cell.

[69]  C. Heldin,et al.  Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. , 1991, The Journal of biological chemistry.

[70]  Jonathan A. Cooper,et al.  Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for phosphatidylinositol 3 kinase. , 1990, The EMBO journal.